Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › NVS
GLENVIEW CAPITAL MANAGEMENT, LLC position in NVS
NOVARTIS AG · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 86,909 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 0.22% of its reported portfolio and ranking #48 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed NVS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's NVS position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in NVS in Q2 2026 at 86,909 shares (US$13.6M). Across 2 filings, GLENVIEW CAPITAL MANAGEMENT, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 86,909 shares valued at US$12.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 86.91K | $13.62M | New |
| Q3 2026 | 86.91K | $12.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held NVS?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed NVS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in NVS?
As of Q3 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 86.91K shares of NVS (NOVARTIS AG), valued at $12.39M, representing 0.22% of its reported portfolio and ranking #48.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling NVS?
In the latest 13F filing (Q3 2026), GLENVIEW CAPITAL MANAGEMENT, LLC held unchanged its position in NVS.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.